EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 84 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,543 | -24.0% | 5,066 | 0.0% | 0.00% | – |
Q4 2022 | $5,978 | -84.3% | 5,066 | 0.0% | 0.00% | – |
Q3 2022 | $38,000 | +40.7% | 5,066 | +17.1% | 0.00% | – |
Q2 2022 | $27,000 | +22.7% | 4,327 | +62.0% | 0.00% | – |
Q1 2022 | $22,000 | +57.1% | 2,671 | 0.0% | 0.00% | – |
Q4 2021 | $14,000 | -22.2% | 2,671 | 0.0% | 0.00% | – |
Q3 2021 | $18,000 | -21.7% | 2,671 | 0.0% | 0.00% | – |
Q2 2021 | $23,000 | -25.8% | 2,671 | -24.3% | 0.00% | – |
Q1 2021 | $31,000 | -31.1% | 3,528 | -3.8% | 0.00% | – |
Q4 2020 | $45,000 | +66.7% | 3,669 | +10.4% | 0.00% | – |
Q3 2020 | $27,000 | -28.9% | 3,322 | -16.1% | 0.00% | – |
Q2 2020 | $38,000 | +40.7% | 3,959 | -0.9% | 0.00% | – |
Q1 2020 | $27,000 | -62.5% | 3,993 | -17.2% | 0.00% | – |
Q4 2019 | $72,000 | +80.0% | 4,822 | +23.3% | 0.00% | – |
Q3 2019 | $40,000 | -2.4% | 3,912 | 0.0% | 0.00% | – |
Q2 2019 | $41,000 | +310.0% | 3,912 | +327.5% | 0.00% | – |
Q1 2017 | $10,000 | 0.0% | 915 | 0.0% | 0.00% | – |
Q4 2016 | $10,000 | – | 915 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
P.A.W. CAPITAL CORP | 540,000 | $4,482,000 | 4.68% |
Knoll Capital Management, LLC | 694,232 | $5,762,000 | 3.62% |
Telemetry Investments, L.L.C. | 213,000 | $1,768,000 | 2.79% |
ACT CAPITAL MANAGEMENT, LLC | 250,000 | $2,075,000 | 2.20% |
VR Adviser, LLC | 1,469,767 | $12,199,000 | 1.98% |
INTERWEST VENTURE MANAGEMENT CO | 560,990 | $4,656,000 | 1.78% |
683 Capital Management, LLC | 3,375,000 | $28,013,000 | 1.50% |
Trellus Management Company, LLC | 300,000 | $2,490,000 | 1.45% |
Altium Capital Management LP | 440,000 | $3,652,000 | 1.22% |
CAXTON CORP | 116,884 | $970,000 | 1.21% |